Status:
ACTIVE_NOT_RECRUITING
Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids
Lead Sponsor:
Superior University
Conditions:
Vernal Keratoconjunctivitis
Eligibility:
All Genders
5-25 years
Brief Summary
This prospective observational cohort study aims to assess changes in central corneal thickness (CCT) in vernal keratoconjunctivitis (VKC) patients using topical steroids. Data will be collected from ...
Detailed Description
A total of 34 participants, including an adjustment for a 10% dropout rate, will be recruited using purposive sampling. The study will last six months. Eligible participants (aged 5-25 years) must hav...
Eligibility Criteria
Inclusion
- Young adults aged between 5-25 years
- Confirmed diagnosis of VKC
- Currently prescribe topical steroid e.g, dexamethasone, prednisolone
- No prior history of corneal surgery or trauma
- Willing to attend follow-up visits and comply with the treatment protocol.
Exclusion
- History of ocular surgery or trauma
- Presence of other corneal pathologies (e.g., Keratoconus)
- Systemic immunosuppressant use or history of systemic steroid use in the past 06 months
- Use of other medications that could influence corneal thickness e.g, antiglaucoma drugs
- Contact lens use within 1 month prior to the study
- Severe dry eye or another ocular surface disease"
Key Trial Info
Start Date :
March 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2026
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06913790
Start Date
March 20 2025
End Date
February 20 2026
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Mustafa eye hospital lahore
Lahore, Punjab Province, Pakistan